In Maryland, Lyme disease (LD) is the most widely reported tickborne disease. All laboratories and healthcare providers are required to report LD cases to the local health department. Given the large volume of LD reports, the nuances of diagnosing and reporting LD, and the effort required for investigations by local health department staff, surveillance for LD is burdensome and subject to underreporting. To determine the degree to which misclassification occurs in Maryland, we reviewed medical records for a sample of LD reports from 2009. We characterized what proportion of suspected and "not a case" reports could be reclassified as confirmed or probable once additional information was obtained from medical record review, explored the reasons for misclassification, and determined multipliers for a more accurate number of LD cases. We reviewed medical records for reports originally classified as suspected (n = 44) and "not a case" (n = 92). Of these 136 records, 31 (23%) suspected cases and "not a case" reports were reclassified. We calculated multipliers and applied them to the case counts from 2009, and estimate an additional 269 confirmed and probable cases, a 13.3% increase. Reasons for misclassification fell into three general categories: lack of clinical or diagnostic information from the provider; surveillance process errors; and incomplete information provided on laboratory reports. These multipliers can be used to calculate a better approximation of the true number of LD cases in Maryland, but these multipliers only account for underreporting due to misclassification, and do not account for cases that are not reported at all (e.g., LD diagnoses based on erythema migrans alone that are not reported) or for cases that are not investigated. Knowing that misclassification of cases occurs during the existing LD surveillance process underscores the complexities of LD surveillance, which further reinforces the need to find alternative approaches to LD surveillance.
| INTRODUC TI ON
Lyme disease (LD) is the most commonly reported tickborne disease in the United States, and the true number of LD cases could be as much as 10 times higher than what is reported through public health surveillance (Hinckley et al., 2014; Nelson et al., 2015) . The reasons that LD is underreported are varied and not entirely understood.
One possible contributing factor is that during the public health sur- clinical information were provided, suspected cases could potentially be classified differently. LD reports not classified as confirmed, probable or suspected cases are deemed "not a case." These reports include those for which LD was actually ruled out, those for which reported clinical information was not related to LD, as well as those which lacked enough information to be otherwise classified (i.e., positive first-tier tests only).
To determine the degree to which misclassification occurs in Maryland, the Maryland Emerging Infections Program reviewed medical records for a sample of LD reports from 2009 captured through the public health surveillance process. We calculated multipliers from the suspected and "not a case" reports that were reclassified and applied these to the total number of suspected and "not a case" reported to better estimate the number of LD cases in Maryland in 2009. We also explored the reasons for misclassification of reported LD cases and determined which provider specialties most commonly diagnose LD to identify where to focus education and intervention efforts to improve LD surveillance.
| MATERIAL AND ME THODS
As part of efforts described previously (Rutz, Hogan, Hook, Hinckley, & Feldman, 2018) , we sampled LD reports submitted to the Maryland Department of Health in 2009. We took a 10% random sample of confirmed, probable and suspected LD cases. In addition, we sampled the following categories of reports that were classified as "not a case": (a) 100% of "not a case" reports submitted by physicians, which contained positive first-tier tests or IgM Western blot tests only and limited, if any, clinical information; and (b) a 10% random sample of "not a case" reports submitted by laboratories that had a positive Western blot test result (>99% were IgM Western blot positive). We did not sample the remaining "not a case" reports which were primarily positive first-tier tests submitted by laboratories with little to no clinical data and were therefore unlikely to have the potential to be reclassified ( Table 1 ).
Given that suspected cases are classified as such due to having positive LD tests in the absence of clinical data, we assumed that these cases had a high potential to be reclassified with additional information as determined through medical record review. We therefore requested and attempted medical record reviews for 100% of the sampled suspected reports. However, given resource availability and our assumption that the "not a case" reports had a lower likelihood of being reclassified, we conducted medical record reviews for 25% of the sampled "not a case" reports submitted by physicians and 50% of the sampled "not a case," Western blot positive reports (Table 1) .
With the additional information gained from medical record review, the reports were reclassified, when indicated, according to the 2008 national case definition for LD. We calculated multipliers for suspected and "not a case" LD reports that were reclassified, and we characterized the reasons that LD reports were originally misclassified. The multipliers were used to estimate the actual
Impacts
• Misclassification of Lyme disease case reports decreased the number of confirmed and probable Lyme disease cases reported for Maryland by 13.3%.
• Reasons for misclassification included: lack of clinical or diagnostic information; surveillance process errors; and incomplete information provided on laboratory reports.
• Clinicians specializing in family medicine, internal medicine and paediatrics were most likely to diagnose cases of Lyme disease. Providers in these specialties should be targeted for education regarding public health reporting or to establish sentinel networks.
• Our results underscore the need to find alternative approaches for Lyme disease surveillance 
| RE SULTS
Of 4,768 LD reports received in 2009, our final sample included 474 confirmed, probable, suspected, and "not a case" reports (Table 1) .
We reviewed 136 medical records, including 44 suspected cases; 75
"not a case," Western blot positive reports; and 17 "not a case," physician submitted reports. All medical records were reviewed on site at the facility. Eight of the 52 suspected medical records were not reviewed as the patient moved out of state and took their records with them, the practice closed, the provider retired or the records were lost.
A total of 292 healthcare practices (accounting for the 474 reports) were surveyed; we obtained responses from 184 (63%) healthcare facilities. The most commonly reported specialty was family medicine, with a total of 80 (43%) facilities having at least one family medicine practitioner. At least one internal medicine specialist was reported at 59 (32%) facilities and at least one paediatrics specialist at 46 (25%) facilities. Few facilities reported having specialists in emergency medicine (n = 7, 4%), dermatology (n = 9, 5%) or infectious disease (n = 9, 5%).
| Reclassification and calculation of multipliers
Following medical record review, a total of 31 (23%) suspected cases and "not a case" reports were reclassified ( Table 2) . Half of the originally classified suspected reports changed classification: 36%
were reclassified as confirmed or probable, and 14% were reclassified as "not a case". Most "not a case" reports retained their original classification: a total of 9% of "not a case," Western blot positive reports were reclassified to suspected, probable or confirmed cases, and 12% of "not a case," physician submitted reports were reclassified as probable or confirmed cases.
Applying these multipliers to the total case counts of suspected an estimated total of 2,298, a 13.3% increase.
| Reasons for misclassification
Reasons why the 31 suspected cases and "not a case" reports were originally misclassified fell into three general categories: lack of clinical or diagnostic information from the provider during the public health surveillance investigation process (n = 19); surveillance process errors (n = 8); and incomplete information provided on laboratory reports to local health departments (n = 4). Surveillance process errors consisted of surveillance staff overlooking critical information on the case report form, incorrectly interpreting LD test results, or not linking critical testing data reported at different times.
Incomplete information on laboratory reports obscured the fact that LD testing had been performed on synovial fluid (which is not included in the case definition for laboratory evidence of infection) because the specimen type was not specified on the laboratory reports sent to the local health departments.
| D ISCUSS I ON
Through our efforts, we have characterized practices that are most likely to encounter and report LD cases; determined multipliers to estimate actual confirmed and probable cases for our suspected cases and "not a case" reports; and identified reasons for misclassification of reported suspected cases and "not a case" reports. This study allowed us to better estimate the amount of underreporting of LD due to misclassification in Maryland. That misclassification of cases occurs during the existing LD surveillance process underscores the complexities of LD surveillance, which further reinforces the need to find alternative approaches to LD surveillance. However, with the status quo, training in conducting LD and other infectious disease investigations for surveillance staff could reduce some surveillance process errors.
Additionally, targeted education on LD reporting among the types of medical practices identified in this study may reduce underreporting.
